Diabetes Telemedicine Consultation: A Systems Improvement Intervention
Diabetes Mellitus Type 2, Diabetes Mellitus, Type 1, Primary Care Provider
About this trial
This is an interventional health services research trial for Diabetes Mellitus Type 2 focused on measuring Diabetes Mellitus, Telemedicine, Referral, Consultation
Eligibility Criteria
Inclusion Criteria: 1) Current prescription of insulin or an oral hypoglycemic agent 2) A1c > 7.0% 3) fasting glucose levels > 130 mg/dl 4) referred to see a consultant and are seen during the active intervention phase. Patients with either Type I or Type II DM will be included A Primary Care Provider for a Cleveland CBOC Exclusion Criteria: 1) primary care obtained at more than one site (based on stop codes with evidence of more than 1 CBOC involved in care during the last 6 months) 2) documented dementia, aphasia, and psychosis
Sites / Locations
- VA Ann Arbor Healthcare System
- Louis Stokes VA Medical Center
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
No Intervention
No Intervention
Telemedicine CBOC
Control CBOC
Provider Interviews
Designated CBOC's were involved in the intervention phase where their Diabetes Mellitus (DM) patients were asked to participate in a telemedicine visit. The Behavioral: The Diabetes Treatment Satisfaction Questionnaire given during this phase along with the Behavioral: Diabetes Empowerment Scale and the Behavioral: CBOC's undergo half-day joint-clinics via teleconference.
The CBOC's not involved in the intervention phase had their patients not be involved in the telemedicine visit, but traditional education.
Qualitative interviews with providers